Positive neuropathic sensory symptoms as endpoints in diabetic neuropathy trials.
about
Treatment of symptomatic polyneuropathy with actovegin in type 2 diabetic patientsPathways in the diagnosis and management of diabetic polyneuropathyAdvances in the diagnosis and management of diabetic distal symmetric polyneuropathy.Explanations for the lower rates of diabetic neuropathy in Indian Asians versus EuropeansDiabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments.Foot deformity in charcot marie tooth disease according to disease severity.Altered excitation-inhibition balance in the brain of patients with diabetic neuropathyEvaluation of the efficacy and safety of pregabalin, venlafaxine, and carbamazepine in patients with painful diabetic peripheral neuropathy. A randomized, double-blind trial.Mouse models of diabetic neuropathyNoninvasive and minimally invasive detection and monitoring of peripheral neuropathies.Mouse models of diabetic neuropathy.Diabetic polyneuropathies: update on research definition, diagnostic criteria and estimation of severity.Recent advances in the management of diabetic distal symmetrical polyneuropathyEmblica officinalis corrects functional, biochemical and molecular deficits in experimental diabetic neuropathy by targeting the oxido-nitrosative stress mediated inflammatory cascade.A randomized controlled trial of the effects of a combination of static and dynamic magnetic fields on carpal tunnel syndrome.
P2860
Q24646981-63E42058-9FD3-4024-B83F-0431E13E2357Q28082465-280B7B04-34E5-4B80-A289-1B71B74DB8A2Q33701317-DCA5A6D2-BFA4-4150-8E11-C03FA2EFBADFQ33873151-C5BA173E-8944-4FD6-BD18-5E568781B4F2Q34153575-CD1E57C1-6220-4C1D-86E1-4224ACC5F835Q35843341-E5830965-4030-49CA-8258-19FB0FD839A5Q36030396-14A5B564-904E-463F-98AB-F87C4EB05719Q36504620-DDBD9C0B-5FB2-4143-98DA-8E3C30F2AE6DQ37062972-AA07A5BF-F75B-42A8-9AF9-72EC853605B7Q37352042-8A61258F-933B-419B-99D8-AE871BEE236FQ37655239-F99FFF4B-0299-48B7-B672-23C2E0E5CD7EQ37893102-87474485-3B50-4289-B1A5-C5B94324420FQ38213043-840555F8-1056-40DE-91D1-1F1C516D48C1Q39269541-EDAC152D-E45D-4DA8-B7DA-73D852EB7049Q47358583-F1497496-F7C8-4A32-9FBD-1F6196F37755
P2860
Positive neuropathic sensory symptoms as endpoints in diabetic neuropathy trials.
description
2001 nî lūn-bûn
@nan
2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Positive neuropathic sensory symptoms as endpoints in diabetic neuropathy trials.
@ast
Positive neuropathic sensory symptoms as endpoints in diabetic neuropathy trials.
@en
Positive neuropathic sensory symptoms as endpoints in diabetic neuropathy trials.
@nl
type
label
Positive neuropathic sensory symptoms as endpoints in diabetic neuropathy trials.
@ast
Positive neuropathic sensory symptoms as endpoints in diabetic neuropathy trials.
@en
Positive neuropathic sensory symptoms as endpoints in diabetic neuropathy trials.
@nl
altLabel
Positive neuropathic sensory symptoms as endpoints in diabetic neuropathy trials
@en
prefLabel
Positive neuropathic sensory symptoms as endpoints in diabetic neuropathy trials.
@ast
Positive neuropathic sensory symptoms as endpoints in diabetic neuropathy trials.
@en
Positive neuropathic sensory symptoms as endpoints in diabetic neuropathy trials.
@nl
P2093
P1476
Positive neuropathic sensory symptoms as endpoints in diabetic neuropathy trials
@en
P2093
A J Windebank
A K Asbury
Ad Hoc Panel on Endpoints for Diabetic Neuropathy Trials
D W Zochodne
F J Service
H L Fields
P356
10.1016/S0022-510X(01)00584-6
P407
P577
2001-08-01T00:00:00Z